Global Next Generation Cancer Diagnostic Devices Market Research Report 2020

1.1 Product Overview and Scope of Next Generation Cancer Diagnostic Devices

1.2 Next Generation Cancer Diagnostic Devices Segment by Type

1.2.1 Global Next Generation Cancer Diagnostic Devices Production Growth Rate Comparison by Type 2020 VS 2026

1.2.2 Next Generation Sequencing

1.2.3 qPCR & Multiplexing

1.2.4 Lab-on- a- chip (LOAC)

1.2.5 Protein Microarrays

1.2.6 DNA Microarrays

1.2.7 Reverse Transcriptase-PCR (RT-PCR)

1.3 Next Generation Cancer Diagnostic Devices Segment by Application

1.3.1 Next Generation Cancer Diagnostic Devices Consumption Comparison by Application: 2020 VS 2026

1.3.2 Biomarker Development

1.3.3 CTC Analysis

1.3.4 Proteomic Analysis

1.3.5 Epigenetic Analysis

1.3.6 Genetic Analysis

1.4 Global Next Generation Cancer Diagnostic Devices Market by Region

1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size Estimates and Forecasts by Region: 2020 VS 2026

1.4.2 North America Estimates and Forecasts (2015-2026)

1.4.3 Europe Estimates and Forecasts (2015-2026)

1.4.4 China Estimates and Forecasts (2015-2026)

1.4.5 Japan Estimates and Forecasts (2015-2026)

1.5 Global Next Generation Cancer Diagnostic Devices Growth Prospects

1.5.1 Global Next Generation Cancer Diagnostic Devices Revenue Estimates and Forecasts (2015-2026)

1.5.2 Global Next Generation Cancer Diagnostic Devices Production Capacity Estimates and Forecasts (2015-2026)

1.5.3 Global Next Generation Cancer Diagnostic Devices Production Estimates and Forecasts (2015-2026)

1.6 Next Generation Cancer Diagnostic Devices Industry

1.7 Next Generation Cancer Diagnostic Devices Market Trends

2 Market Competition by Manufacturers

2.1 Global Next Generation Cancer Diagnostic Devices Production Capacity Market Share by Manufacturers (2015-2020)

2.2 Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2015-2020)

2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.4 Global Next Generation Cancer Diagnostic Devices Average Price by Manufacturers (2015-2020)

2.5 Manufacturers Next Generation Cancer Diagnostic Devices Production Sites, Area Served, Product Types

2.6 Next Generation Cancer Diagnostic Devices Market Competitive Situation and Trends

2.6.1 Next Generation Cancer Diagnostic Devices Market Concentration Rate

2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue

2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

3.1 Global Production Capacity of Next Generation Cancer Diagnostic Devices Market Share by Regions (2015-2020)

3.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Regions (2015-2020)

3.3 Global Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.4 North America Next Generation Cancer Diagnostic Devices Production

3.4.1 North America Next Generation Cancer Diagnostic Devices Production Growth Rate (2015-2020)

3.4.2 North America Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.5 Europe Next Generation Cancer Diagnostic Devices Production

3.5.1 Europe Next Generation Cancer Diagnostic Devices Production Growth Rate (2015-2020)

3.5.2 Europe Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.6 China Next Generation Cancer Diagnostic Devices Production

3.6.1 China Next Generation Cancer Diagnostic Devices Production Growth Rate (2015-2020)

3.6.2 China Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

3.7 Japan Next Generation Cancer Diagnostic Devices Production

3.7.1 Japan Next Generation Cancer Diagnostic Devices Production Growth Rate (2015-2020)

3.7.2 Japan Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

4 Global Next Generation Cancer Diagnostic Devices Consumption by Regions

4.1 Global Next Generation Cancer Diagnostic Devices Consumption by Regions

4.1.1 Global Next Generation Cancer Diagnostic Devices Consumption by Region

4.1.2 Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Region

4.2 North America

4.2.1 North America Next Generation Cancer Diagnostic Devices Consumption by Countries

4.2.2 U.S.

4.2.3 Canada

4.3 Europe

4.3.1 Europe Next Generation Cancer Diagnostic Devices Consumption by Countries

4.3.2 Germany

4.3.3 France

4.3.4 U.K.

4.3.5 Italy

4.3.6 Russia

4.4 Asia Pacific

4.4.1 Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Region

4.4.2 China

4.4.3 Japan

4.4.4 South Korea

4.4.5 Taiwan

4.4.6 Southeast Asia

4.4.7 India

4.4.8 Australia

4.5 Latin America

4.5.1 Latin America Next Generation Cancer Diagnostic Devices Consumption by Countries

4.5.2 Mexico

4.5.3 Brazil

5 Next Generation Cancer Diagnostic Devices Production, Revenue, Price Trend by Type

5.1 Global Next Generation Cancer Diagnostic Devices Production Market Share by Type (2015-2020)

5.2 Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Type (2015-2020)

5.3 Global Next Generation Cancer Diagnostic Devices Price by Type (2015-2020)

5.4 Global Next Generation Cancer Diagnostic Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

6 Global Next Generation Cancer Diagnostic Devices Market Analysis by Application

6.1 Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application (2015-2020)

6.2 Global Next Generation Cancer Diagnostic Devices Consumption Growth Rate by Application (2015-2020)

7 Company Profiles and Key Figures in Next Generation Cancer Diagnostic Devices Business

7.1 Roche Holding Ltd.（Switzerland)

7.1.1 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.1.2 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.1.3 Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.1.4 Roche Holding Ltd.（Switzerland) Main Business and Markets Served

7.2 Abbott Laboratories(US)

7.2.1 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.2.2 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.2.4 Abbott Laboratories(US) Main Business and Markets Served

7.3 Siemens Healthcare(Germany)

7.3.1 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.3.2 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.3.4 Siemens Healthcare(Germany) Main Business and Markets Served

7.4 Agilent Technologies Inc(Germany)

7.4.1 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.4.2 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.4.4 Agilent Technologies Inc(Germany) Main Business and Markets Served

7.5 Illumina Inc.(US)

7.5.1 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.5.2 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.5.4 Illumina Inc.(US) Main Business and Markets Served

7.6 Becton Dickinson and Co.(US)

7.6.1 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.6.2 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.6.4 Becton Dickinson and Co.(US) Main Business and Markets Served

7.7 QIAGEN N.V.(Germany)

7.7.1 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.7.2 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.7.4 QIAGEN N.V.(Germany) Main Business and Markets Served

7.8 Affymetrix Inc.(US)

7.8.1 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.8.2 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.8.4 Affymetrix Inc.(US) Main Business and Markets Served

7.9 Johnson & Johnson(US)

7.9.1 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.9.2 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.9.4 Johnson & Johnson(US) Main Business and Markets Served

7.10 Thermo Fisher Scientific Inc.(US)

7.10.1 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.10.2 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.10.4 Thermo Fisher Scientific Inc.(US) Main Business and Markets Served

7.11 GE Healthcare(England)

7.11.1 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.11.2 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.11.4 GE Healthcare(England) Main Business and Markets Served

7.12 Life Technologies Corp.(US)

7.12.1 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.12.2 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.12.4 Life Technologies Corp.(US) Main Business and Markets Served

7.13 Luminex Corp.(US)

7.13.1 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.13.2 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.13.4 Luminex Corp.(US) Main Business and Markets Served

7.14 Cepheid Inc.(US)

7.14.1 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.14.2 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.14.4 Cepheid Inc.(US) Main Business and Markets Served

7.15 Allegro Diagnostics Corp.(Brazil)

7.15.1 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

7.15.2 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Product Introduction, Application and Specification

7.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Production Capacity, Revenue, Price and Gross Margin (2015-2020)

7.15.4 Allegro Diagnostics Corp.(Brazil) Main Business and Markets Served

8 Next Generation Cancer Diagnostic Devices Manufacturing Cost Analysis

8.1 Next Generation Cancer Diagnostic Devices Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Raw Materials Price Trend

8.1.3 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices

8.4 Next Generation Cancer Diagnostic Devices Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Next Generation Cancer Diagnostic Devices Distributors List

9.3 Next Generation Cancer Diagnostic Devices Customers

10 Market Dynamics

10.1 Market Trends

10.2 Opportunities and Drivers

10.3 Challenges

10.4 Porter's Five Forces Analysis

11 Production and Supply Forecast

11.1 Global Forecasted Production of Next Generation Cancer Diagnostic Devices (2021-2026)

11.2 Global Forecasted Revenue of Next Generation Cancer Diagnostic Devices (2021-2026)

11.3 Global Forecasted Price of Next Generation Cancer Diagnostic Devices (2021-2026)

11.4 Global Next Generation Cancer Diagnostic Devices Production Forecast by Regions (2021-2026)

11.4.1 North America Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)

11.4.2 Europe Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)

11.4.3 China Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)

11.4.4 Japan Next Generation Cancer Diagnostic Devices Production, Revenue Forecast (2021-2026)

12 Consumption and Demand Forecast

12.1 Global Forecasted and Consumption Demand Analysis of Next Generation Cancer Diagnostic Devices

12.2 North America Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country

12.3 Europe Market Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Country

12.4 Asia Pacific Market Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Regions

12.5 Latin America Forecasted Consumption of Next Generation Cancer Diagnostic Devices

13 Forecast by Type and by Application (2021-2026)

13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)

13.1.1 Global Forecasted Production of Next Generation Cancer Diagnostic Devices by Type (2021-2026)

13.1.2 Global Forecasted Revenue of Next Generation Cancer Diagnostic Devices by Type (2021-2026)

13.1.2 Global Forecasted Price of Next Generation Cancer Diagnostic Devices by Type (2021-2026)

13.2 Global Forecasted Consumption of Next Generation Cancer Diagnostic Devices by Application (2021-2026)

14 Research Finding and Conclusion

15 Methodology and Data Source

15.1 Methodology/Research Approach

15.1.1 Research Programs/Design

15.1.2 Market Size Estimation

15.1.3 Market Breakdown and Data Triangulation

15.2 Data Source

15.2.1 Secondary Sources

15.2.2 Primary Sources

15.3 Author List

15.4 Disclaimer

Table 1. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) Growth Rate Comparison by Type (2015-2026)

Table 2. Global Next Generation Cancer Diagnostic Devices Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026)

Table 3. Global Next Generation Cancer Diagnostic Devices Consumption (K Pcs) Comparison by Application: 2020 VS 2026

Table 4. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) by Manufacturers

Table 5. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) by Manufacturers (2015-2020)

Table 6. Global Next Generation Cancer Diagnostic Devices Production Share by Manufacturers (2015-2020)

Table 7. Global Next Generation Cancer Diagnostic Devices Revenue (Million USD) by Manufacturers (2015-2020)

Table 8. Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers (2015-2020)

Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Next Generation Cancer Diagnostic Devices as of 2019)

Table 10. Global Market Next Generation Cancer Diagnostic Devices Average Price (USD/Pcs) of Key Manufacturers (2015-2020)

Table 11. Manufacturers Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 12. Manufacturers Next Generation Cancer Diagnostic Devices Product Types

Table 13. Global Next Generation Cancer Diagnostic Devices Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion

Table 15. Global Next Generation Cancer Diagnostic Devices Capacity (K Pcs) by Region (2015-2020)

Table 16. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) by Region (2015-2020)

Table 17. Global Next Generation Cancer Diagnostic Devices Revenue (Million US$) by Region (2015-2020)

Table 18. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2015-2020)

Table 19. Global Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 20. North America Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 21. Europe Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 22. China Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 23. Japan Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 24. Global Next Generation Cancer Diagnostic Devices Consumption (K Pcs) Market by Region (2015-2020)

Table 25. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Region (2015-2020)

Table 26. North America Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)

Table 27. Europe Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)

Table 28. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)

Table 29. Latin America Next Generation Cancer Diagnostic Devices Consumption by Countries (2015-2020) (K Pcs)

Table 30. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) by Type (2015-2020)

Table 31. Global Next Generation Cancer Diagnostic Devices Production Share by Type (2015-2020)

Table 32. Global Next Generation Cancer Diagnostic Devices Revenue (Million US$) by Type (2015-2020)

Table 33. Global Next Generation Cancer Diagnostic Devices Revenue Share by Type (2015-2020)

Table 34. Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs) by Type (2015-2020)

Table 35. Global Next Generation Cancer Diagnostic Devices Consumption (K Pcs) by Application (2015-2020)

Table 36. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application (2015-2020)

Table 37. Global Next Generation Cancer Diagnostic Devices Consumption Growth Rate by Application (2015-2020)

Table 38. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 39. Roche Holding Ltd.（Switzerland) Production Sites and Area Served

Table 40. Roche Holding Ltd.（Switzerland) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 41. Roche Holding Ltd.（Switzerland) Main Business and Markets Served

Table 42. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 43. Abbott Laboratories(US) Production Sites and Area Served

Table 44. Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 45. Abbott Laboratories(US) Main Business and Markets Served

Table 46. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 47. Siemens Healthcare(Germany) Production Sites and Area Served

Table 48. Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 49. Siemens Healthcare(Germany) Main Business and Markets Served

Table 50. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 51. Agilent Technologies Inc(Germany) Production Sites and Area Served

Table 52. Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 53. Agilent Technologies Inc(Germany) Main Business and Markets Served

Table 54. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 55. Illumina Inc.(US) Production Sites and Area Served

Table 56. Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 57. Illumina Inc.(US) Main Business and Markets Served

Table 58. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 59. Becton Dickinson and Co.(US) Production Sites and Area Served

Table 60. Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 61. Becton Dickinson and Co.(US) Main Business and Markets Served

Table 62. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 63. QIAGEN N.V.(Germany) Production Sites and Area Served

Table 64. QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 65. QIAGEN N.V.(Germany) Main Business and Markets Served

Table 66. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 67. Affymetrix Inc.(US) Production Sites and Area Served

Table 68. Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 69. Affymetrix Inc.(US) Main Business and Markets Served

Table 70. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 71. Johnson & Johnson(US) Production Sites and Area Served

Table 72. Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 73. Johnson & Johnson(US) Main Business and Markets Served

Table 74. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 75. Thermo Fisher Scientific Inc.(US) Production Sites and Area Served

Table 76. Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 77. Thermo Fisher Scientific Inc.(US) Main Business and Markets Served

Table 78. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 79. GE Healthcare(England) Production Sites and Area Served

Table 80. GE Healthcare(England) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 81. GE Healthcare(England) Main Business and Markets Served

Table 82. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 83. Life Technologies Corp.(US) Production Sites and Area Served

Table 84. Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 85. Life Technologies Corp.(US) Main Business and Markets Served

Table 86. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 87. Luminex Corp.(US) Production Sites and Area Served

Table 88. Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 89. Luminex Corp.(US) Main Business and Markets Served

Table 90. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 91. Cepheid Inc.(US) Production Sites and Area Served

Table 92. Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 93. Cepheid Inc.(US) Main Business and Markets Served

Table 94. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Production Sites and Area Served

Table 95. Allegro Diagnostics Corp.(Brazil) Production Sites and Area Served

Table 96. Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 97. Allegro Diagnostics Corp.(Brazil) Main Business and Markets Served

Table 98. Production Base and Market Concentration Rate of Raw Material

Table 99. Key Suppliers of Raw Materials

Table 100. Next Generation Cancer Diagnostic Devices Distributors List

Table 101. Next Generation Cancer Diagnostic Devices Customers List

Table 102. Market Key Trends

Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 104. Key Challenges

Table 105. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) Forecast by Region (2021-2026)

Table 106. North America Next Generation Cancer Diagnostic Devices Consumption Forecast 2021-2026 (K Pcs) by Country

Table 107. Europe Next Generation Cancer Diagnostic Devices Consumption Forecast 2021-2026 (K Pcs) by Country

Table 108. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Forecast 2021-2026 (K Pcs) by Regions

Table 109. Latin America Next Generation Cancer Diagnostic Devices Consumption Forecast 2021-2026 (K Pcs) by Country

Table 110. Global Next Generation Cancer Diagnostic Devices Consumption (K Pcs) Forecast by Regions (2021-2026)

Table 111. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) Forecast by Type (2021-2026)

Table 112. Global Next Generation Cancer Diagnostic Devices Revenue (Million US$) Forecast by Type (2021-2026)

Table 113. Global Next Generation Cancer Diagnostic Devices Price (USD/Pcs) Forecast by Type (2021-2026)

Table 114. Global Next Generation Cancer Diagnostic Devices Consumption (K Pcs) Forecast by Application (2021-2026)

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Picture of Next Generation Cancer Diagnostic Devices

Figure 2. Global Next Generation Cancer Diagnostic Devices Production Market Share by Type: 2020 VS 2026

Figure 3. Next Generation Sequencing Product Picture

Figure 4. qPCR & Multiplexing Product Picture

Figure 5. Lab-on- a- chip (LOAC) Product Picture

Figure 6. Protein Microarrays Product Picture

Figure 7. DNA Microarrays Product Picture

Figure 8. Reverse Transcriptase-PCR (RT-PCR) Product Picture

Figure 9. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application: 2020 VS 2026

Figure 10. Biomarker Development

Figure 11. CTC Analysis

Figure 12. Proteomic Analysis

Figure 13. Epigenetic Analysis

Figure 14. Genetic Analysis

Figure 15. North America Next Generation Cancer Diagnostic Devices Revenue (Million US$) and Growth Rate (2015-2026)

Figure 16. Europe Next Generation Cancer Diagnostic Devices Revenue (Million US$) and Growth Rate (2015-2026)

Figure 17. China Next Generation Cancer Diagnostic Devices Revenue (Million US$) and Growth Rate (2015-2026)

Figure 18. Japan Next Generation Cancer Diagnostic Devices Revenue (Million US$) and Growth Rate (2015-2026)

Figure 19. Global Next Generation Cancer Diagnostic Devices Revenue (Million US$) (2015-2026)

Figure 20. Global Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs) (2015-2026)

Figure 21. Next Generation Cancer Diagnostic Devices Production Share by Manufacturers in 2019

Figure 22. Global Next Generation Cancer Diagnostic Devices Revenue Share by Manufacturers in 2019

Figure 23. Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 24. Global Market Next Generation Cancer Diagnostic Devices Average Price (USD/Pcs) of Key Manufacturers in 2019

Figure 25. The Global 5 and 10 Largest Players: Market Share by Next Generation Cancer Diagnostic Devices Revenue in 2019

Figure 26. Global Next Generation Cancer Diagnostic Devices Production Market Share by Region (2015-2020)

Figure 27. Global Next Generation Cancer Diagnostic Devices Production Market Share by Region in 2019

Figure 28. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region (2015-2020)

Figure 29. Global Next Generation Cancer Diagnostic Devices Revenue Market Share by Region in 2019

Figure 30. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) Growth Rate (2015-2020)

Figure 31. North America Next Generation Cancer Diagnostic Devices Production (K Pcs) Growth Rate (2015-2020)

Figure 32. Europe Next Generation Cancer Diagnostic Devices Production (K Pcs) Growth Rate (2015-2020)

Figure 33. China Next Generation Cancer Diagnostic Devices Production (K Pcs) Growth Rate (2015-2020)

Figure 34. Japan Next Generation Cancer Diagnostic Devices Production (K Pcs) Growth Rate (2015-2020)

Figure 35. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Region (2015-2020)

Figure 36. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Region in 2019

Figure 37. North America Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 38. North America Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019

Figure 39. Canada Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 40. U.S. Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 41. Europe Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 42. Europe Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019

Figure 43. Germany America Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 44. France Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 45. U.K. Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 46. Italy Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 47. Russia Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 48. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 49. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption Market Share by Regions in 2019

Figure 50. China Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 51. Japan Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 52. South Korea Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 53. Taiwan Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 54. Southeast Asia Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 55. India Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 56. Australia Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 57. Latin America Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 58. Latin America Next Generation Cancer Diagnostic Devices Consumption Market Share by Countries in 2019

Figure 59. Mexico Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 60. Brazil Next Generation Cancer Diagnostic Devices Consumption Growth Rate (2015-2020) (K Pcs)

Figure 61. Production Market Share of Next Generation Cancer Diagnostic Devices by Type (2015-2020)

Figure 62. Production Market Share of Next Generation Cancer Diagnostic Devices by Type in 2019

Figure 63. Revenue Share of Next Generation Cancer Diagnostic Devices by Type (2015-2020)

Figure 64. Revenue Market Share of Next Generation Cancer Diagnostic Devices by Type in 2019

Figure 65. Global Next Generation Cancer Diagnostic Devices Production Growth by Type (2015-2020) (K Pcs)

Figure 66. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application (2015-2020)

Figure 67. Global Next Generation Cancer Diagnostic Devices Consumption Market Share by Application in 2019

Figure 68. Global Next Generation Cancer Diagnostic Devices Consumption Growth Rate by Application (2015-2020)

Figure 69. Price Trend of Key Raw Materials

Figure 70. Manufacturing Cost Structure of Next Generation Cancer Diagnostic Devices

Figure 71. Manufacturing Process Analysis of Next Generation Cancer Diagnostic Devices

Figure 72. Next Generation Cancer Diagnostic Devices Industrial Chain Analysis

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles

Figure 75. Porter's Five Forces Analysis

Figure 76. Global Next Generation Cancer Diagnostic Devices Production Capacity (K Pcs) and Growth Rate Forecast (2021-2026)

Figure 77. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) and Growth Rate Forecast (2021-2026)

Figure 78. Global Next Generation Cancer Diagnostic Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 79. Global Next Generation Cancer Diagnostic Devices Price and Trend Forecast (2021-2026)

Figure 80. Global Next Generation Cancer Diagnostic Devices Production Market Share Forecast by Region (2021-2026)

Figure 81. North America Next Generation Cancer Diagnostic Devices Production (K Pcs) and Growth Rate Forecast (2021-2026)

Figure 82. North America Next Generation Cancer Diagnostic Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 83. Europe Next Generation Cancer Diagnostic Devices Production (K Pcs) and Growth Rate Forecast (2021-2026)

Figure 84. Europe Next Generation Cancer Diagnostic Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 85. China Next Generation Cancer Diagnostic Devices Production (K Pcs) and Growth Rate Forecast (2021-2026)

Figure 86. China Next Generation Cancer Diagnostic Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 87. Japan Next Generation Cancer Diagnostic Devices Production (K Pcs) and Growth Rate Forecast (2021-2026)

Figure 88. Japan Next Generation Cancer Diagnostic Devices Revenue (Million US$) and Growth Rate Forecast (2021-2026)

Figure 89. Global Forecasted and Consumption Demand Analysis of Next Generation Cancer Diagnostic Devices

Figure 90. North America Next Generation Cancer Diagnostic Devices Consumption (K Pcs) Growth Rate Forecast (2021-2026)

Figure 91. Europe Next Generation Cancer Diagnostic Devices Consumption (K Pcs) Growth Rate Forecast (2021-2026)

Figure 92. Asia Pacific Next Generation Cancer Diagnostic Devices Consumption (K Pcs) Growth Rate Forecast (2021-2026)

Figure 93. Latin America Next Generation Cancer Diagnostic Devices Consumption (K Pcs) Growth Rate Forecast (2021-2026)

Figure 94. Global Next Generation Cancer Diagnostic Devices Production (K Pcs) Forecast by Type (2021-2026)

Figure 95. Global Next Generation Cancer Diagnostic Devices Revenue Market Share Forecast by Type (2021-2026)

Figure 96. Global Next Generation Cancer Diagnostic Devices Consumption Forecast by Application (2021-2026)

Figure 97. Bottom-up and Top-down Approaches for This Report

Figure 98. Data Triangulation